Pupillary dilatation is seen in which of the following drug classes?
In strychnine poisoning, convulsions occur because of the antagonist effects at receptors for:
What is the type of inhibition of acetylcholinesterase caused by organophosphates?
Which of the following local anesthetics is NOT used as a surface anesthetic?
Which of the following drugs is an immunostimulant?
Amyl nitrite is used as an antidote in which poisoning?
Therapeutic drug monitoring is advised in all the following drugs except?
All of the following statements about Trientine are true, EXCEPT:
Which of the following is NOT a manifestation of anaphylactic shock?
Hypoglycemia caused by anti-hyperglycemic drugs like sulfonylureas can be classified as which type of adverse drug reaction?
Explanation: **Explanation:** The correct answer is **Belladonna alkaloids** (Option B). **1. Why Belladonna alkaloids are correct:** Belladonna alkaloids, such as **Atropine** and Scopolamine, are competitive antagonists of muscarinic acetylcholine receptors. In the eye, they block the M3 receptors on the circular muscle (sphincter pupillae) of the iris. This prevents parasympathetic-mediated pupillary constriction, leading to unopposed action of the radial muscle (dilator pupillae), resulting in **Mydriasis** (pupillary dilatation). They also cause cycloplegia (paralysis of accommodation) by blocking M3 receptors on the ciliary muscle. **2. Why other options are incorrect:** * **Organophosphorus compounds (A):** These are irreversible acetylcholinesterase inhibitors. They lead to an accumulation of acetylcholine at the motor endplate and synapses, causing excessive stimulation of M3 receptors, which results in **pinpoint pupils (Miosis)**. * **Heroin (C) and Morphine (D):** Both are opioids that stimulate the Edinger-Westphal nucleus (parasympathetic nucleus of the oculomotor nerve). This central stimulation leads to intense pupillary constriction, classically described as **"pinpoint pupils."** **Clinical Pearls for NEET-PG:** * **Mydriasis (Dilated pupils):** Seen in "Sympathomimetics" (Cocaine, Amphetamines) and "Anticholinergics" (Atropine, Datura). * **Miosis (Constricted pupils):** Remember the mnemonic **"P-O-N-S"** (Pontine hemorrhage, Opioids, Nicotine/Nerve gas, Sedatives/Sartans/Strychnine). * **Diagnostic Tip:** In a comatose patient, pinpoint pupils that are non-reactive to light strongly suggest **Opioid poisoning** or a **Pontine infarct**. * **Atropine** is the specific antidote for Organophosphorus poisoning to reverse the life-threatening muscarinic effects.
Explanation: Strychnine is a potent neurotoxin derived from the seeds of the *Strychnos nux-vomica* plant. Its primary mechanism of action is the **competitive antagonism of Glycine receptors**, specifically at the postsynaptic sites in the Renshaw cells of the spinal cord [1].1. **Why Glycine is correct:** Glycine is the major **inhibitory neurotransmitter** in the spinal cord [1]. Under normal conditions, it prevents excessive motor neuron firing. Strychnine blocks these glycine receptors, removing the "inhibitory brakes" on motor neurons [1]. This leads to unchecked sensory stimulation, resulting in severe, symmetric, tonic-clonic convulsions and characteristic muscle spasms.2. **Why other options are incorrect:** * **GABA:** While GABA is the primary inhibitory neurotransmitter in the brain, its antagonism is associated with toxins like **Picrotoxin** or **Bicuculline**, not strychnine. * **Glutamate & Aspartate:** These are the primary **excitatory** neurotransmitters in the CNS. Antagonizing these would typically lead to CNS depression or anticonvulsant effects, rather than causing convulsions.**Clinical Pearls for NEET-PG:** * **Risus Sardonicus:** Strychnine poisoning causes a characteristic fixed grin due to spasms of facial muscles (similar to Tetanus). * **Opisthotonus:** Severe hyperextension and arching of the back due to powerful contraction of extensor muscles. * **Consciousness:** Unlike many other seizure-inducing toxins, the patient remains **fully conscious** and in extreme pain until death (usually from asphyxia due to diaphragmatic spasm). * **Management:** Treatment involves aggressive airway management, benzodiazepines (to control spasms), and avoiding external stimuli (noise/light) which can trigger convulsions.
Explanation: ### Explanation **Correct Answer: D. Competitive and irreversible** **Mechanism of Action:** Organophosphates (OPs) act by inhibiting the enzyme **Acetylcholinesterase (AChE)** [2]. They bind to the **esteratic site** of the enzyme, the same site where the substrate (Acetylcholine) normally binds, making the inhibition **competitive** in nature. The bond formed is a stable **covalent phosphate bond** [3]. Initially, this bond can be broken by oximes (like Pralidoxime), but over time, the enzyme-inhibitor complex undergoes a process called **"Aging"** (loss of an alkyl group) [3]. Once aging occurs, the bond becomes extremely stable and permanent, rendering the inhibition **irreversible**. The body must then synthesize new AChE enzymes to restore function, which takes weeks. **Why other options are incorrect:** * **A & C (Reversible):** Reversible inhibitors like Edrophonium (non-covalent) or Neostigmine (carbamates) bind temporarily [1]. OPs are unique because their covalent phosphorylation leads to permanent inactivation. * **B (Noncompetitive):** Noncompetitive inhibitors bind to an allosteric site. Since OPs compete with Acetylcholine for the active esteratic site, they are classified as competitive. **NEET-PG High-Yield Pearls:** * **Clinical Presentation:** Features of "Cholinergic Crisis" (DUMBELS: Defecation, Urination, Miosis, Bronchospasm/Bradycardia, Emesis, Lacrimation, Salivation). * **Antidote of Choice:** **Atropine** (Muscarinic antagonist). It is titrated until secretions dry up and the heart rate increases. * **Enzyme Reactivators:** **Oximes (Pralidoxime/PAM)** are effective only *before* aging occurs [3]. They do not work for Carbamate poisoning. * **Most common cause of death:** Respiratory failure (due to central depression, bronchoconstriction, and diaphragmatic paralysis).
Explanation: **Explanation:** Local anesthetics (LAs) are classified based on their ability to penetrate mucous membranes and skin. To be effective as a **surface (topical) anesthetic**, a drug must have high lipid solubility and the ability to penetrate intact or broken surfaces to reach nerve endings. **Why Bupivacaine is the Correct Answer:** Bupivacaine is a potent, long-acting amide local anesthetic. However, it has **poor penetrative capacity** through mucous membranes and skin. Therefore, it is ineffective as a surface anesthetic. Its clinical utility is strictly limited to infiltration, nerve blocks, epidural, and spinal anesthesia. **Analysis of Incorrect Options:** * **Lidocaine:** The most versatile LA. It has excellent penetrative power and is used topically as a jelly (for catheterization), spray (for intubation), or ointment. * **Tetracaine:** An ester LA with high lipid solubility and potency. It is widely used as a surface anesthetic, particularly in ophthalmology (eye drops) and for spinal anesthesia. * **Cocaine:** The only naturally occurring LA. It has intrinsic vasoconstrictor properties and is an excellent surface anesthetic, historically used for ENT procedures. **NEET-PG High-Yield Pearls:** * **Surface Anesthetics:** Include Lidocaine, Tetracaine, Cocaine, Benzocaine, and Proparacaine. * **Non-Surface Anesthetics:** Include Bupivacaine, Procaine, and Chloroprocaine (these are poorly absorbed topically). * **Bupivacaine Toxicity:** It is highly **cardiotoxic** (blocks cardiac sodium channels during diastole). Intravenous lipid emulsion (20%) is the antidote for systemic toxicity. * **EMLA Cream:** A eutectic mixture of Lidocaine and Prilocaine used for topical anesthesia on intact skin.
Explanation: **Explanation:** **Levamisole** is the correct answer because it is a synthetic imidazothiazole derivative that acts as an **immunomodulator/immunostimulant**. It works by restoring depressed T-cell and macrophage function, stimulating phagocytosis, and enhancing chemotaxis. While originally developed as an anthelmintic (anti-worm) medication, its immunostimulant properties led to its clinical use in conditions like colon cancer (as an adjuvant with 5-Fluorouracil) and certain autoimmune disorders, though its use is now limited due to side effects like agranulocytosis. **Analysis of Incorrect Options:** * **Prednisolone (A):** A potent glucocorticoid that acts as a broad-spectrum **immunosuppressant** by inhibiting the transcription of pro-inflammatory cytokines and suppressing T-cell activation. * **Cyclosporine (C):** A calcineurin inhibitor that specifically inhibits IL-2 production. It is a classic **immunosuppressant** used to prevent graft rejection in organ transplants. * **Thalidomide (D):** Primarily classified as an **immunosuppressant** and anti-angiogenic agent. It inhibits TNF-α and is used in Erythema Nodosum Leprosum (ENL) and Multiple Myeloma. **NEET-PG High-Yield Pearls:** * **Levamisole’s "Other" Use:** It is still used in pediatric nephrology for **frequently relapsing minimal change disease (MCD)** to maintain remission. * **BCG Vaccine:** Another important immunostimulant used intravesically for superficial bladder cancer. * **Cytokines:** Interferons (IFN-α, β, γ) and Interleukin-2 (Aldesleukin) are also categorized as immunostimulants used in viral hepatitis and malignancies (Renal Cell Carcinoma/Melanoma). * **Side Effect Alert:** Always associate Levamisole with **agranulocytosis** and multifocal leukoencephalopathy.
Explanation: **Explanation:** **Cyanide poisoning** is the correct answer. Cyanide is a potent cellular toxin that binds to the ferric ($Fe^{3+}$) iron of **cytochrome oxidase a3** in the mitochondrial electron transport chain, halting aerobic respiration and causing "histotoxic hypoxia." **Mechanism of Action:** Amyl nitrite (and sodium nitrite) acts by oxidizing the ferrous iron ($Fe^{2+}$) in hemoglobin to ferric iron ($Fe^{3+}$), forming **methemoglobin**. Methemoglobin has a higher affinity for cyanide than cytochrome oxidase does. It "sequesters" cyanide from the mitochondria to form **cyanmethemoglobin**, thereby restoring cellular respiration. This is typically followed by sodium thiosulfate administration, which converts cyanmethemoglobin into non-toxic thiocyanate for renal excretion. **Analysis of Incorrect Options:** * **Cholinesterase (Organophosphates):** The antidote is **Atropine** (muscarinic antagonist) and **Pralidoxime** (PAM), which reactivates the enzyme. * **Benzodiazepines:** The specific antidote is **Flumazenil**, a competitive GABA-A receptor antagonist. * **Barbiturates:** There is no specific pharmacological antidote; management is supportive, involving gastric lavage and **urinary alkalinization** (using Sodium Bicarbonate) to enhance excretion. **High-Yield Clinical Pearls for NEET-PG:** * **Cyanide Antidote Kit:** Includes Amyl nitrite (inhaled), Sodium nitrite (IV), and Sodium thiosulfate (IV). * **Hydroxocobalamin:** Now preferred over nitrites in many settings as it binds cyanide to form Vitamin B12 (cyanocobalamin) without inducing methemoglobinemia. * **Side Effect:** A major risk of nitrite therapy is excessive methemoglobinemia, which reduces the oxygen-carrying capacity of the blood. The antidote for severe methemoglobinemia is **Methylene Blue**.
Explanation: Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring drug concentrations in the blood to maintain a constant concentration within a specific **therapeutic window** [1]. It is indicated for drugs with a narrow therapeutic index, unpredictable pharmacokinetics, or where toxicity is difficult to distinguish from the disease process. **Why Metformin is the correct answer:** Metformin has a **wide therapeutic index** and its clinical effect (blood glucose levels) can be easily monitored using pharmacodynamic markers like HbA1c or fasting blood glucose [4]. There is no established correlation between plasma metformin levels and its glucose-lowering effect or the risk of lactic acidosis. Therefore, TDM is not required. **Why the other options are incorrect:** * **Phenytoin:** It follows **zero-order (non-linear) kinetics** at high therapeutic doses [2]. Small dose increments can lead to disproportionately large increases in plasma levels, causing neurotoxicity (ataxia, nystagmus) [5]. * **Tacrolimus & Cyclosporine:** These are **calcineurin inhibitors** used in organ transplants. They have a very narrow therapeutic window; sub-therapeutic levels lead to graft rejection, while supra-therapeutic levels cause significant nephrotoxicity and neurotoxicity [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Indications for TDM:** Narrow therapeutic index (Lithium, Digoxin, Aminoglycosides), drugs with saturable metabolism (Phenytoin), and to check compliance [2]. * **Drugs NOT requiring TDM:** Drugs whose effects are easily measured (Antihypertensives, Hypoglycemics, Anticoagulants like Warfarin—monitored via PT/INR) [4], and "hit and run" drugs (Omeprazole). * **Lithium** is the most common drug requiring TDM in psychiatry (Target: 0.6–1.2 mEq/L). * **Digoxin** TDM is done at least 6–8 hours after the last dose to allow for tissue distribution.
Explanation: **Explanation:** Trientine (triethylenetetramine) is a copper-chelating agent used primarily in the management of **Wilson’s disease**. **1. Why Option A is the Correct Answer (The False Statement):** While Trientine is orally absorbed, it is **less potent** than D-penicillamine. Penicillamine remains the first-line chelator due to its higher efficacy in inducing cupriuresis. Trientine is generally reserved as a second-line agent for patients who are intolerant to penicillamine (e.g., those developing nephrotic syndrome or lupus-like reactions). **2. Analysis of Other Options:** * **Option B:** Trientine is the standard **alternative** for patients who cannot tolerate penicillamine due to its different chemical structure and lower incidence of hypersensitivity reactions. * **Option C:** Trientine can chelate dietary iron, forming a complex that is not absorbed. Therefore, it should **not be co-administered with iron** supplements within a 2-hour window to prevent decreased efficacy of both drugs. * **Option D:** Because it can interfere with iron absorption and potentially chelate systemic iron, prolonged use may lead to **iron deficiency anemia**. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** It is a polyamine chelator that promotes the urinary excretion of copper. * **Adverse Effects:** Though safer than penicillamine, it can cause sideroblastic anemia and systemic lupus erythematosus (rarely). * **Pregnancy:** It is considered safer than penicillamine during pregnancy for Wilson’s disease. * **Drug of Choice (DOC):** While penicillamine is the DOC for Wilson's disease, **Zinc** is preferred for maintenance therapy or asymptomatic patients as it inhibits intestinal copper absorption.
Explanation: **Explanation:** Anaphylactic shock is a **Type I Hypersensitivity reaction** mediated by IgE antibodies, leading to the massive release of histamine and other inflammatory mediators (like leukotrienes and prostaglandins) from mast cells and basophils. **Why Vasoconstriction is the Correct Answer:** The hallmark of anaphylaxis is **systemic vasodilation** (not vasoconstriction). Histamine acts on H1 and H2 receptors in the vascular smooth muscle, causing profound peripheral vasodilation and increased capillary permeability. This leads to a relative hypovolemia and a "distributive" shock. Therefore, vasoconstriction is physiologically opposite to what occurs in anaphylaxis. **Analysis of Incorrect Options:** * **Hypotension:** This occurs due to the sudden decrease in systemic vascular resistance (vasodilation) and the leakage of fluid into the extravascular space (third-spacing). * **Bronchospasm:** Histamine and leukotrienes cause contraction of the bronchial smooth muscle, leading to wheezing and respiratory distress. * **Laryngeal Edema:** Increased capillary permeability causes rapid swelling of the upper airway tissues, which is a life-threatening cause of airway obstruction in anaphylaxis. **High-Yield Clinical Pearls for NEET-PG:** 1. **Drug of Choice:** **Adrenaline (Epinephrine)** is the first-line treatment. It acts as a physiological antagonist. 2. **Mechanism of Adrenaline:** It causes **vasoconstriction (α1)** to reverse hypotension, **bronchodilation (β2)** to relieve bronchospasm, and inhibits further mediator release (β2). 3. **Route & Dose:** The preferred route is **Intramuscular (IM)** in the anterolateral thigh. The standard dose is **0.5 mg (1:1000 concentration)** for adults. 4. **Biphasic Reaction:** Symptoms can recur 1–72 hours after initial resolution; hence, patients should be monitored.
Explanation: **Explanation:** Adverse Drug Reactions (ADRs) are most commonly classified using the **Rawlins and Thompson classification**. **1. Why Option A is Correct:** **Type A (Augmented)** reactions are dose-dependent, predictable based on the known pharmacology of the drug, and have high morbidity but low mortality. * **Mechanism:** Sulfonylureas (e.g., Glimepiride) work by stimulating insulin release from pancreatic beta cells. Hypoglycemia is a direct, exaggerated extension of this intended pharmacological action. If the dose is too high or the patient fasts, the drug "over-performs," leading to low blood glucose. **2. Why Other Options are Incorrect:** * **Type B (Bizarre):** These are unpredictable, dose-independent, and not related to the drug's known action (e.g., Anaphylaxis with Penicillin or Stevens-Johnson Syndrome). * **Type C (Chronic/Continuous):** These occur due to long-term drug use (e.g., Analgesic nephropathy or Iatrogenic Cushing’s syndrome from steroids). * **Type D (Delayed):** These manifest long after the drug exposure, such as teratogenicity (e.g., Thalidomide) or carcinogenicity. **Clinical Pearls for NEET-PG:** * **Type E (End-of-use):** Withdrawal symptoms (e.g., seizures after stopping Benzodiazepines). * **Type F (Failure):** Unexpected failure of therapy (e.g., drug interactions reducing the efficacy of Oral Contraceptive Pills). * **High-Yield Fact:** Most ADRs (approx. 80%) encountered in clinical practice are **Type A**, making them preventable by dosage adjustment.
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free